SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-035944
Filing Date
2019-06-17
Accepted
2019-06-17 16:06:21
Documents
1
Period of Report
2019-06-05

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1469
  Complete submission text file 0001104659-19-035944.txt   2773
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Issuer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 78 BLANCHARD ROAD BURLINGTON MA 01803
Business Address
Windham-Bannister Susan Richards (Reporting) CIK: 0001713760 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38630 | Film No.: 19901479